Three Types of Racing Upgrades Offered by Hypercar Development

An accomplished entrepreneur based in Anaheim, California, Manny Bojorquez has successfully launched several businesses across different industries. Among Manny Bojorquez’s successful ventures is Hypercar Development, which offers racing upgrades for high-end vehicles like McLarens.

Hypercar Development features three levels of performance upgrades for McLaren race car drivers. The first level, called Phase 1, makes adjustments to a stock McLaren to help it reach an output of 800 horsepower. These upgrades include equipping the car with ultralight wheels made of aerospace aluminum and Michelin Pilot Sport Cup 2 tires. This phase also gives the vehicle a high-flowing full exhaust system and additional heat shielding.

Phase 2 of Hypercar can help drivers break the 1,000-horsepower barrier. To reach that level of speed, technicians upgrade the vehicle’s transmission, driveline, fuel system, and engine blueprint. Phase 2 also includes installation of a patented tri-boost turbocharging system and redesigned aerodynamics to draw maximum performance from the engine enhancements.

Finally, drivers who opt for Hypercar Phase 3 can achieve up to 1,200 horsepower. Also powered by the tri-boost turbocharger, Phase 3 vehicles benefit from additional engine enhancements, further aerodynamic improvements, and suspension upgrades to make them among the fastest vehicles on the track.

How PEA Works to Reduce the Need for Opioids

With an extensive entrepreneurial background, Manny Bojorquez leads companies in areas such as high-end performance vehicles and California legal and medical assistance. Among Manny Bojorquez’s current ventures is peaCURE, which emphasizes a natural supplementation approach through the anti-inflammatory palmitoylethanolamide (PEA).

One of the vital uses of PEA is in helping alleviate the opioid crisis by offering a natural alternative that is safe and effective for managing chronic pain. A major issue for people who use opioids is persistent mast cell activation, which serves to sensitize nociceptors and jumpstart inflammatory processes in the central nervous system.

At the cellular level, this involves sensitization of somatosensory neurons in the spine and microglial cell activation. With opioids highly effective in activating non-neuronal immune cell populations, the end result is that pro-inflammatory and pro-nociceptive processes are promoted, which increases tolerance to the dangerous drugs.

PEA plays a critical role in mediating inflammatory process resolution and helping maintain cellular homeostasis. It down-modulates the activation of microglia and mast cells and reduces the neuropathic pain and inflammation associated with acute stimuli. These analgesic and anti-inflammatory effects target the pathophysiologic mechanisms associated with chronic pain and can thus reduce opioid dependence.

International Mile Racing Association Sanctions Mile-Long Races

Orange County, California-based entrepreneur Manny Bojorquez leads a diverse array of businesses, including companies that provide customized parts for high-end performance vehicles. Possessing an interest in a variety of racing events, Manny Bojorquez is a member of the International Mile Racing Association (IMRA).

IMRA is not a race organizer, but a sanctioning body for the sport of mile automotive racing that ensures adherence to safety protocols and competition rules across various venues. IMRA sanctions specific types of auto races, including a “Standing Mile” race, where vehicles begin from a stopped position and rapidly accelerate throughout the whole mile race. The winner is the driver with the highest mile-per-hour (MPH) reading at the end of the race.

Other IMRA-sanctioned races include the “Flying Mile,” where vehicles have a 300-foot head start to begin accelerating before reaching the start line, and the “ET Mile,” which differs from the others because the elapsed time, rather than the final MPH reading, is used to determine the winner. Additionally, the association sanctions half-mile, quarter-mile, and 1.75 “Flying Mile” races.

IMRA is also responsible for inspecting the vehicles and courses for safety. Sanctioned race tracks must be at least 45-feet wide and 9,000-feet long for mile-long racing events.

McLaren - Sleek Elegance Meets High-Function at Automotive Plant

An Orange County, California, entrepreneur, Manny Bojorquez has directed successful ventures that encompass the automotive equipment, food manufacturing, health care, and legal services markets. Manny Bojorquez currently leads, among other companies, HyperCar Development, which focuses on producing customized products designed to enhance the performance of McLaren racing cars in particular.

The McLaren is an ultra-high-status make of grand prix racer with individual vehicles typically selling for six figures, some close to $1 million or more.

The McLaren Group at the McLaren Technology Centre in Surrey, England, manufacture the cars in a state-of-the-art facility whose design and precision performance standards are in keeping with those of the vehicles themselves.

Close to the town of Woking, architects Foster + Partners created a circle-shaped central site, then separated it into two distinct black-and-white, yin-and-yang-shaped portions. Reviewing the main structure in 2003, The Guardian noted that the yin-yang configuration so noticeable from the air is in fact the interlocking of a curve-shaped factory building nestled against an artificial lake.

The McLaren plant could not be more different, in style and in its awareness of its environment, from the smoke-churning car manufacturing plants that typified the 20th century.

The elegant complex features a two-story, dome-topped visitor learning center designed to make the company an integral part of its local community and a focal point for high-technology manufacturing that can serve as a benchmark for other carmakers. Saplings screen the factory from the road, and the native fauna are at home in the surrounding greenbelt.

Three of the Most Common Causes for Workplace Injuries

California-based entrepreneur Manny Bojorquez leverages more than two decades of experience in management, marketing, sales, and strategic planning to guide companies in various industries. Manny Bojorquez’s ventures include Legal Advisors, Medical Assistance (LAMA), which serves as a resource for those seeking medical and/or legal aid following a work- or negligence-related injury.

Although injuries are not uncommon in the workplace, many are preventable with proper safety and equipment-maintenance measures. People who experience such accidents can face medical and financial challenges that severely affect their life or ability to work, so taking the necessary steps to avoid them is critical. The following list comprises some of the most common causes for occupational injuries:

- Overexertion and repetitive motion injuries. Too much physically intensive work can contribute to a range of muscular disorders and long-lasting medical complications. Accounting for approximately 33 percent of all workplace injuries, overexertion can result from strenuous carrying, holding, pulling, and pushing of heavy objects. Repetitive stress can occur from performing the same motion continuously or from jobs that cause poor posture.

- Slips, trips, and falls. The second most common type of injuries, slips, trips, and falls make up about one-third of workplace accidents. These can result from a wide range of oversights, from slippery or wet floors and uneven walking surfaces to poor lighting and weather hazards. The implementation of safety and cleaning protocols can prevent such occurrences.

- Mechanical hazards. Moving or heavy machinery without proper guards, maintenance, or safety procedures can result in objects and body parts becoming caught in or entangled with them. In addition to their moving parts, machinery can cause injury while being used at the point of operations or via malfunctioning power-transmission system components.

Ford F-150 Raptor Offers Technologies That Drive Off-Road Performance

Southern California entrepreneur Manny Bojorquez has guided growth firms to successful outcomes in a variety of industries spanning legal, medical advice, and automotive performance. In the latter sphere, Manny Bojorquez leads HyperCar Development, where, as its owner and operator, he customizes rugged vehicles such as the Ford Raptor off-road truck.

The 2019 Ford F-150 Raptor is designed to do well in various rough-terrain situations, including trails and dry lakebeds. With standard Trail Control, the driver does not need to brake or throttle, as the technology allows the vehicle to tackle slopes and inclines at optimal speed.

The Fox shocks hold up admirably in any terrain, while the Live Valve system offers an electronic adjusting damper. Taking in inputs such as steering, brakes, throttle, and road conditions, the vehicle adjusts in real time for peak performance. A new option is Recaro seats with Alcantara inserts that take the classic Ford GT supercar as their inspiration.

HyperCar Development’s upgrade selections for the Ford Raptor include carbon fiber hood vents, offroad tuning modules, and side exit exhaust systems.

PEA - A Naturally Occurring Substance That Offers Pain Relief

Based in California, entrepreneur Manny Bojorquez has launched multiple companies including HyperCar Development and ZipTuning USA. In addition, Manny Bojorquez oversees operations for the all-natural pharmaceutical development business peaCURE. Striving to become a leader in science-based approaches to natural healing, the company combines research-proven ingredients with purity testing to produce effective pharmaceuticals.

The company’s proprietary product is a line of supplements and medical foods containing pure palmitoylethanolamide (PEA), a fatty acid amide that naturally occurs in the body. Its production appears to be a response to inflammation, and it interferes with processes involved with chronic pain and inflammation by binding to the receptors in the cell's nucleus. Studies on PEA indicate that it can benefit individuals with afflictions such as peripheral neuropathy, fibromyalgia, and chronic regional pain syndrome (CRPS) by blocking or inhibiting the systems that trigger pain receptors. 

Although other countries began research on PEA’s potential as an alternative to opioids in treating chronic pain conditions decades ago, its use and appeal is only now steadily gaining traction in medical circles within the US. This growing interest has led to new research and clinical trials on PEA-based medications and treatments, peaCURE among them. Its appeal largely stems from its lack of side effects and inability to cause an overdose, since the substance is found naturally inside the body. 

For more information on peaCURE, visit peacure.com.